A scientific paper recently published by CHEST Journal, shares a study that finds CLEW Medical’s FDA-cleared AI-driven models for predicting patient deterioration were five times more accurate than alerts from a leading telemedicine system. from NEW STUDY FINDS AI-DRIVEN PREDICTION MODELS ACCURATELY PREDICT CRITICAL CARE PATIENT DETERIORATION AND SIGNIFICANTLY REDUCE FALSE ALARMS FOR CLINICIANS
Category: News
AI in High-Acuity Telehealth Care: The CLEW AI and Equum Medical Partnership
AI in High-Acuity Telehealth Care: The CLEW AI and Equum Medical Partnership from AI in High-Acuity Telehealth Care: The CLEW AI and Equum Medical Partnership
CLEW Announces Tele-ICU Conversion and Accelerator Program
Rapid and risk-free migration from legacy Philips eICU® to CLEW’s FDA-cleared AI Tele-ICU platform from CLEW Announces Tele-ICU Conversion and Accelerator Program
CLEW announces appointment of Paul Roscoe as CEO
CLEW, a provider of real-time AI analytics platforms for healthcare, today announced that its board of directors has named Paul Roscoe as its new CEO, responsible for leading the growth of CLEW worldwide. from CLEW announces appointment of Paul Roscoe as CEO
Penn State Health to Pioneer Next-Generation Virtual ICUs with CLEW Medical’s AI Powered Cloud-based Platform
Bringing virtualICU services in-house and offering them to both owned and referral hospitals in the region, to better manage capacity and address provider shortages driven by prolonged pandemic and burnout. from Penn State Health to Pioneer Next-Generation Virtual ICUs with CLEW Medical’s AI Powered Cloud-based Platform
Equum and CLEW join forces on telehealth services in acute critical care
AI-based clinical decision support tools support more proactive care and increased physician productivity from Equum and CLEW join forces on telehealth services in acute critical care
CLEW Registered for CE Expanding its Commercial Reach in the European market
To improve the efficiency of the European healthcare system, the innovative CLEWICU solution identifies patients with an increased likelihood of being diagnosed with respiratory failure or hemodynamic instability, prioritizes workflow and treatment, and optimizes the allocation of critical care resources from CLEW Registered for CE Expanding its Commercial Reach in the European market
Healthcare industry professionals Ron Greeno and Mike Murphy join CLEW Medical’s Advisory Board
The highly experienced healthcare executives will advise CLEW Medical as the company expands its product offering in North America following FDA 510k approval from Healthcare industry professionals Ron Greeno and Mike Murphy join CLEW Medical’s Advisory Board
Healthcare IT Today FDA Approves Use of AI Tool Predicting Adverse Events In ICU
CLEW trained its AI using data on nearly 100,000 patients in ICUs. The AI-based algorithms are machine-learning models trained to predict such problems hours in advance. The product, CLEW-ICU, integrates care delivered by local and remote teams. According to the vendor, this clearance is the FDA’s first for technology in this category. from Healthcare IT Today FDA Approves Use of AI Tool Predicting Adverse Events In ICU
HHM Global: CLEW Medical receives FDA approval for AI-based tech to support adult ICU patient assessment
The healthcare technology revolution: AI-assisted doctors CLEWICU is the industry’s first-ever cleared device for predicting the likelihood of patient deterioration up to 8 hours in advance based on hemodynamic instability, enabling earlier evaluation and subsequent care plans. from HHM Global: CLEW Medical receives FDA approval for AI-based tech to support adult ICU patient assessment
